You don't typically see companies come out and make statements like that unless they really think the rules were changed on them. I think the larger story here has been just the degradation at The Biologics center has seen 106 departures since the beginning of the year. That's on top of about 150 RIFs that were also part of that center. If you look at the drug center, they lost about a third of the reviewers that review breast and gynecological cancer products. (07:41–07:46)
CLAIM
Asserts that 106 staff members have left the Biologics center this year.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.